Evidence map›Paper›PMID 41915126›Full record

ArticleJapanese journal of radiology2026

Lesion conspicuity assessment of prone 40-keV virtual monoenergetic imaging in arterial-phase photon-counting CT for breast cancer: a retrospective comparison with DCE-MRI.

Yusuke Kawasaki, Maika Nakajima, Kota Yokoyama, Emi Yamaga, Makoto Kato, Leona Katsuta, Ken Yamagiwa, Hiroto Hada, Takumi Hiraishi, Hirofumi Yamada and 5 more

Abstract readComparative Study
In one paragraph

Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yusuke KawasakiDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0001-8266-7965
Maika NakajimaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Kota YokoyamaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. kota1986ky@yahoo.co.jp.ORCID http://orcid.org/0000-0001-5151-3146
Emi YamagaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0002-5931-6507
Makoto KatoDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Leona KatsutaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0003-4247-9673
Ken YamagiwaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0001-6987-7407
Hiroto HadaRadiology Center, Institute of Science Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1192-2839
Takumi HiraishiRadiology Center, Institute of Science Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Hirofumi YamadaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0001-7892-8341
Junichi TsuchiyaDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0001-8392-2227
Susumu KirimuraDepartment of Breast Surgery, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0009-0009-8449-2068
Iichiroh OnishiDepartment of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9744-0114
Tomoyuki ArugaDepartment of Breast Surgery, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3442-8972
Ukihide TateishiDepartment of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigated whether contrast enhanced whole-body photon-counting detector (PCD)-CT performed for staging in the prone position can provide breast lesion conspicuity comparable to dynamic contrast-enhanced T1-weighted imaging (DCE-T1WI).

methodsThis single-center, retrospective diagnostic feasibility study included 22 women with surgically confirmed primary breast cancer who underwent preoperative prone PCD-CT and DCE-MRI. Then, 40- and 70-keV virtual monoenergetic image (VMI) from a single arterial-phase PCD-CT acquisition were reconstructed. Three readers independently evaluated 40- and 70-keV VMI and DCE-T1WI. The primary endpoint was lesion conspicuity. The secondary endpoints included, size error, detection rate, background parenchymal enhancement (BPE), subjective noise, and reading time.

resultsLesion conspicuity was highest on 40-keV VMI, which outperformed 70-keV VMI and DCE-T1WI. Absolute size error was numerically larger for 40-keV VMI than for DCE-T1WI, but this difference was not statistically significant. Directional error indicated that 40-keV VMI significantly underestimated lesion size relative to DCE-T1WI. Detection rates showed an overall difference among modalities, but pairwise differences were not statistically significant. Further, 40-keV VMI had a higher BPE and a greater perceived noise than 70-keV VMI, and it required a longer reading time than DCE-T1WI. The radiation dose did not differ between VMI energy levels as both were reconstructed from the same acquisition.

conclusionArterial-phase 40-keV VMIs from prone PCD-CT demonstrated the highest lesion conspicuity and showed better detection capability than 70-keV VMI. In addition, their performance was comparable to or superior to DCE-T1WI. This finding was achieved despite trade-offs in increased noise, BPE and size underestimation. Thus, 40-keV VMI may serve as a useful complementary modality for local breast assessment and may be considered a potential alternative for lesion localization when MRI is not feasible, despite potential underestimation of lesion extent.

Indexed as

Breast NeoplasmsTomography, X-Ray ComputedAdultAgedBreastContrast MediaDynamic Contrast Enhanced Magnetic Resonance ImagingFeasibility StudiesFemaleHumansMiddle AgedPhotonsProne PositionRetrospective StudiesContrast MediaBreast imagingBreast neoplasmsComputed tomographyMagnetic resonance imagingPhoton-countingVirtual monoenergetic imaging

Identifiers

PMID41915126
PMCPMC13315485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.